ArticleEmerging infectious diseases2011
Mycobacterium tuberculosis cluster with developing drug resistance, New York, New York, USA, 2003-2009.
Article in Emerging infectious diseases, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 27 citations in OpenAlex.
- Methods used in the spatial analysis of tuberculosis epidemiology: a systematic review.BMC medicine · 2018Pooled it
- Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review.Journal of substance abuse treatment · 2017Pooled it
- Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014Pooled it
- Article
- Prevalence and Characterization of Heterogeneous Variable-Number Tandem-Repeat Clusters Comprising Drug-Susceptible and/or Variable Resistant Mycobacterium tuberculosis Complex Isolates in the Netherlands from 2004 to 2016.Journal of clinical microbiology · 2018Article
- Where is tuberculosis transmission happening? Insights from the literature, new tools to study transmission and implications for the elimination of tuberculosis.Respirology (Carlton, Vic.) · 2018Review
- Using Reports of Latent Tuberculosis Infection Among Young Children to Identify Tuberculosis Transmission in New York City, 2006-2012.American journal of epidemiology · 2018Article
- Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000-2015.Emerging infectious diseases · 2018Article
- Contemporary Social Disparities in TB Infection and Disease in the USA: a Review.Current epidemiology reports · 2018Article
- Evaluation of 24-locus MIRU-VNTR genotyping in Mycobacterium tuberculosis cluster investigations in four jurisdictions in the United States, 2006-2010.Tuberculosis (Edinburgh, Scotland) · 2017Article
- Epidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City.Antimicrobial agents and chemotherapy · 2015Article
- Disparities in tuberculosis burden among South Asians living in New York City, 2001-2010.American journal of public health · 2015Article
- Mortality among tuberculosis patients with acquired resistance to second-line antituberculosis drugs--United States, 1993-2008.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014Article
- Neighborhood socioeconomic position and tuberculosis transmission: a retrospective cohort study.BMC infectious diseases · 2014Article
- Using statistical methods and genotyping to detect tuberculosis outbreaks.International journal of health geographics · 2013Article
- Using genotyping and geospatial scanning to estimate recent mycobacterium tuberculosis transmission, United States.Emerging infectious diseases · 2012Article
- Characterization of microevolution events in Mycobacterium tuberculosis strains involved in recent transmission clusters.Journal of clinical microbiology · 2011Article
- Isolation of Mycobacterium tuberculosis strains with a silent mutation in rpoB leading to potential misassignment of resistance category.Journal of clinical microbiology · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2004, identification of patients infected with the same Mycobacterium tuberculosis strain in New York, New York, USA, resulted in an outbreak investigation. The investigation involved data collection and analysis, establishing links between patients, and forming transmission hypotheses. Fifty-four geographically clustered cases were identified during 2003-2009. Initially, the M. tuberculosis strain was drug susceptible. However, in 2006, isoniazid resistance emerged, resulting in isoniazid-resistant M. tuberculosis among 17 (31%) patients. Compared with patients with drug-susceptible M. tuberculosis, a greater proportion of patients with isoniazid-resistant M. tuberculosis were US born and had a history of illegal drug use. No patients named one another as contacts. We used patient photographs to identify links between patients. Three links were associated with drug use among patients infected with isoniazid-resistant M. tuberculosis. The photographic method would have been more successful if used earlier in the investigation. Name-based contact investigation might not identify all contacts, particularly when illegal drug use is involved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.